The double antibody drug conjugate (DAD) phase I trial: Sacituzumab govitecan (SG) plus enfortumab vedotin (EV) as >= second-line therapy for metastatic urothelial carcinoma (mUC)
Enfortumab Vedotin;Sacituzumab Govitecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: The double antibody drug conjugate (DAD) phase I trial: Sacituzumab govitecan (SG) plus enfortumab vedotin (EV) as >= second-line therapy for metastatic urothelial carcinoma (mUC) ### Output: Enfortumab Vedotin;Sacituzumab Govitecan